13F-HR filed by Nextech Invest Ltd.
Nextech Invest Ltd. filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 14 holding rows worth $309,620,000.
- Accession
- 0001104659-22-118489
- Filer
- CIK 1911010
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 14 entries on the cover page, a total value of $309,620,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $309,620,000 with VALUE read as thousands by filing date, 13F file number 028-22157. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 4,189,529 | $82,618,000 | thousands by filing date | |
| EQRX INC | 26886C107 | COM | 13,104,424 | $64,867,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 2,661,888 | $31,810,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 2,518,582 | $22,138,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 263,914 | $18,432,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 1,385,807 | $16,491,000 | thousands by filing date | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,221,145 | $15,655,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 287,251 | $12,780,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 188,228 | $12,402,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 475,485 | $10,637,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,910,029 | $10,085,000 | thousands by filing date | |
| KRONOS BIO INC | 50107A104 | COM | 1,451,537 | $4,863,000 | thousands by filing date | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 611,310 | $3,546,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 375,857 | $3,296,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-22-118489 | this filing | 2022-11-14 | acceptance time not in the bulk data set |